Total Payments
$14,829
2024 Payments
$2,238
Companies
52
Transactions
818
Medicare Patients
3,172
Medicare Billing
$498,957
Payment Breakdown by Category
Food & Beverage$14,334 (96.7%)
Education$345.38 (2.3%)
Consulting$150.00 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,334 | 812 | 96.7% |
| Education | $345.38 | 5 | 2.3% |
| Consulting Fee | $150.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,253 | 104 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,136 | 173 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,034 | 39 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $917.81 | 50 | $0 (2024) |
| Grifols USA, LLC | $696.73 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $580.10 | 40 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $552.81 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $531.44 | 34 | $0 (2024) |
| GENZYME CORPORATION | $486.48 | 28 | $0 (2024) |
| PFIZER INC. | $462.92 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,238 | 97 | AstraZeneca Pharmaceuticals LP ($492.46) |
| 2023 | $2,308 | 113 | AstraZeneca Pharmaceuticals LP ($493.91) |
| 2022 | $2,634 | 138 | AstraZeneca Pharmaceuticals LP ($539.51) |
| 2021 | $2,005 | 128 | GlaxoSmithKline, LLC. ($335.44) |
| 2020 | $1,718 | 88 | Arbor Pharmaceuticals, Inc. ($333.97) |
| 2019 | $1,320 | 79 | AstraZeneca Pharmaceuticals LP ($166.66) |
| 2018 | $1,350 | 92 | GlaxoSmithKline, LLC. ($168.71) |
| 2017 | $1,256 | 83 | GlaxoSmithKline, LLC. ($184.49) |
All Payment Transactions
818 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Pulmonology | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.18 | General |
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.01 | General |
| Category: Narcoplepsy | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/03/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 729 | 1,419 | $237,435 | $122,811 |
| 2022 | 14 | 890 | 1,685 | $329,610 | $147,361 |
| 2021 | 17 | 770 | 1,381 | $250,090 | $115,376 |
| 2020 | 13 | 783 | 1,359 | $217,455 | $113,409 |
Total Patients
3,172
Total Services
5,844
Medicare Billing
$498,957
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 114 | 480 | $62,400 | $42,849 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 266 | $33,250 | $23,704 | 71.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 85 | 102 | $22,440 | $13,176 | 58.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 180 | $18,000 | $10,562 | 58.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 50 | $16,150 | $8,110 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 127 | $11,430 | $7,620 | 66.7% |
| 32557 | Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | Facility | 2023 | 18 | 48 | $38,400 | $5,399 | 14.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $5,580 | $3,449 | 61.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 50 | 53 | $6,360 | $3,261 | 51.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 24 | 24 | $7,150 | $1,832 | 25.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 23 | 23 | $6,475 | $1,762 | 27.2% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Facility | 2023 | 35 | 35 | $9,800 | $1,087 | 11.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 142 | 482 | $62,660 | $37,334 | 59.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 299 | $37,375 | $26,109 | 69.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 35 | 129 | $39,990 | $21,253 | 53.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 111 | 120 | $26,400 | $18,083 | 68.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 88 | 222 | $22,200 | $11,847 | 53.4% |
| 32557 | Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | Facility | 2022 | 28 | 90 | $72,000 | $10,327 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 135 | $12,150 | $8,309 | 68.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 43 | 43 | $15,050 | $3,785 | 25.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 31 | 31 | $11,625 | $2,997 | 25.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 50 | 51 | $6,120 | $2,728 | 44.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $4,140 | $2,517 | 60.8% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Facility | 2022 | 37 | 38 | $13,300 | $1,246 | 9.4% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 11 | 11 | $4,950 | $708.38 | 14.3% |
About Dr. Pablo Molina, MD
Dr. Pablo Molina, MD is a Critical Care Medicine healthcare provider based in Anderson, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740215805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pablo Molina, MD has received a total of $14,829 in payments from pharmaceutical and medical device companies, with $2,238 received in 2024. These payments were reported across 818 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($14,334).
As a Medicare-enrolled provider, Molina has provided services to 3,172 Medicare beneficiaries, totaling 5,844 services with total Medicare billing of $498,957. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Anderson, IN
- Active Since 07/11/2006
- Last Updated 03/07/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1740215805
Products in Payments
- DUPIXENT (Biological) $1,590
- TRELEGY ELLIPTA (Drug) $962.22
- TEZSPIRE (Biological) $939.86
- NUCALA (Biological) $781.63
- ACTHAR (Biological) $671.37
- Prolastin-C Liquid (Biological) $618.06
- XARELTO (Drug) $580.10
- SYMBICORT (Drug) $553.46
- ELIQUIS (Drug) $527.98
- OFEV (Drug) $520.07
- FASENRA (Biological) $494.45
- XOLAIR (Biological) $419.76
- GLASSIA (Biological) $409.91
- OPSUMIT (Drug) $347.14
- Horizant (Drug) $333.97
- TYVASO (Drug) $240.97
- ZERBAXA (Drug) $239.35
- STIOLTO RESPIMAT (Drug) $217.55
- Yupelri (Drug) $192.61
- Arikayce (Drug) $169.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Anderson
David Mares, Md, MD
Critical Care Medicine — Payments: $1.4M
Critical Care Medicine $1.4M
Stephen Hand, Md, MD
Critical Care Medicine — Payments: $7,712
Critical Care Medicine $7,712
Moayyed Moallem, Md, MD
Critical Care Medicine — Payments: $4,275
Critical Care Medicine $4,275
Anas Alsadi, Md, MD
Critical Care Medicine — Payments: $4,137
Critical Care Medicine $4,137
Thomas Bright, Md, MD
Critical Care Medicine — Payments: $3,291
Critical Care Medicine $3,291
Christine Del Prado-Rico, Md, MD
Critical Care Medicine — Payments: $150.25
Critical Care Medicine $150.25